Results

Latest quarterly results

Companies that reported quarterly results recently, newest first. Each row compares the reported quarter with the same quarter a year earlier. Figures in USD; revenue and net income in millions.

878 companies in Healthcare reported in the last 30 days · showing 151–200 · updated Wed, Nov 18, 2026

CompanySectorReportedQuarter RevenueRev. YoYNet incomeNI YoYEPSEPS YoY Op. marginMargin chg.Market cap
GNPXGenprex, Inc. Healthcare Nov 13 Sep '26 $0.0M n/m −$4.0M n/m −$5.30 n/m — — $843,494
IMCCIM Cannabis Corp. Healthcare Nov 13 Sep '26 $1.1M n/m — n/m −$18.51 n/m -184.4% — $813,367
ASNDAscendis Pharma A/S - Ordinary Share Healthcare Nov 12 Sep '26 $419M +71.5% — n/m $1.24 n/m 33.7% +28.6 pp $17.8B
TWSTTwist Bioscience Corporation Healthcare Nov 12 Sep '26 $127M +28.3% −$21.0M n/m −$0.31 n/m -25.0% +5.3 pp $7.4B
KODKodiak Sciences Inc Healthcare Nov 12 Sep '26 $0.0M n/m $124M n/m −$1.05 n/m — — $6.3B
ARWRArrowhead Pharmaceuticals, Inc. Healthcare Nov 12 Sep '26 $38.0M n/m −$428M n/m −$3.02 n/m — — $6.1B
ERASErasca, Inc. Healthcare Nov 12 Sep '26 $1.0M n/m −$51.0M n/m −$0.13 n/m — — $4.9B
HTFLHeartflow, Inc. Healthcare Nov 12 Sep '26 $73.0M +58.7% −$12.0M n/m −$0.13 n/m -19.0% +13.6 pp $4.1B
SLSSELLAS Life Sciences Group, Inc. Healthcare Nov 12 Sep '26 $0.0M n/m −$10.0M n/m −$0.05 n/m — — $3.9B
PBLSParabilis Medicines, Inc. Healthcare Nov 12 Sep '26 $2.0M — −$44.0M — −$0.36 — — — $3.4B
AVAHAveanna Healthcare Holdings Inc. Healthcare Nov 12 Sep '26 $696M +11.9% $45.0M +221.4% $0.20 +233.3% 12.0% +3.0 pp $2.5B
PHVSPharvaris N.V. Healthcare Nov 12 Sep '26 — n/m — n/m −$0.77 n/m — — $2.3B
ADRXADARx Pharmaceuticals, Inc. Healthcare Nov 12 Sep '26 $2.0M — −$28.0M — −$0.27 — — — $1.5B
ANABAnaptysBio, Inc. Healthcare Nov 12 Sep '26 $30.0M −60.5% $4.0M −73.3% $0.11 −78.8% 65.8% +20.3 pp $1.4B
ABSIAbsci Corporation Healthcare Nov 12 Sep '26 $0.0M n/m −$33.0M n/m −$0.19 n/m — — $1.3B
TSHATaysha Gene Therapies, Inc. Healthcare Nov 12 Sep '26 $0.0M n/m −$39.0M n/m −$0.10 n/m — — $1.3B
GENBGenerate Biomedicines, Inc. Healthcare Nov 12 Sep '26 $4.0M — −$88.0M — −$0.68 — — — $1.3B
AVLNAvalyn Pharma Inc. Healthcare Nov 12 Sep '26 $0.0M — −$30.0M — $0.00 — — — $1.2B
KARDKardigan, Inc. Healthcare Nov 12 Sep '26 $0.0M — −$59.0M — −$0.64 — — — $1.2B
NKTRNektar Therapeutics Healthcare Nov 12 Sep '26 $9.0M −25.0% −$56.0M n/m −$1.63 n/m -615.8% −348.4 pp $1.0B
AKTSAktis Oncology, Inc. Healthcare Nov 12 Sep '26 $4.0M +100.0% −$30.0M n/m −$0.54 n/m -889.8% — $877M
MGTXMeiraGTx Holdings plc Healthcare Nov 12 Sep '26 $5.0M n/m −$51.0M n/m −$0.53 n/m — — $827M
PRMEPrime Medicine, Inc. Healthcare Nov 12 Sep '26 $4.0M +300.0% −$39.0M n/m −$0.22 n/m -947.7% — $699M
SGMTSagimet Biosciences Inc. - Series A Healthcare Nov 12 Sep '26 $0.0M n/m −$19.0M n/m −$0.31 n/m — — $693M
ALMSAlumis Inc. Healthcare Nov 12 Sep '26 $2.0M 0.0% −$95.0M n/m −$0.73 n/m — — $626M
IMMXImmix Biopharma, Inc. Healthcare Nov 12 Sep '26 $0.0M n/m −$14.0M n/m −$0.19 n/m — — $603M
FDMT4D Molecular Therapeutics, Inc. Healthcare Nov 12 Sep '26 $4.0M n/m −$78.0M n/m −$1.08 n/m — — $596M
CBIOCrescent Biopharma, Inc. Healthcare Nov 12 Sep '26 $3.0M n/m −$38.0M n/m −$0.97 n/m — — $507M
MNPRMonopar Therapeutics Inc. Healthcare Nov 12 Sep '26 $0.0M n/m −$6.0M n/m −$0.72 n/m — — $482M
FENCFennec Pharmaceuticals Inc. Healthcare Nov 12 Sep '26 $20.0M +66.7% $5.0M n/m $0.12 n/m 23.7% +25.4 pp $479M
ASMBAssembly Biosciences, Inc. Healthcare Nov 12 Sep '26 $3.0M n/m −$20.0M n/m −$0.93 n/m -792.1% — $461M
DMACDiaMedica Therapeutics Inc. Healthcare Nov 12 Sep '26 $0.0M n/m −$11.0M n/m −$0.21 n/m — — $452M
BLSMBlossomHill Therapeutics, Inc. Healthcare Nov 12 Sep '26 $0.0M — −$24.0M — −$0.88 — — — $440M
CRMDCorMedix Inc. Healthcare Nov 12 Sep '26 $55.0M −47.1% −$15.0M −113.8% −$0.19 −115.1% -12.1% −61.4 pp $371M
PROKProKidney Corp. Healthcare Nov 12 Sep '26 $0.0M n/m −$36.0M n/m −$0.17 n/m — — $370M
CVCapsoVision, Inc. Healthcare Nov 12 Sep '26 $4.0M 0.0% −$7.0M n/m −$0.15 n/m -206.9% −209.7 pp $357M
RLMDRelmada Therapeutics, Inc. Healthcare Nov 12 Sep '26 $0.0M n/m −$14.0M n/m −$0.12 n/m — — $321M
SMTISanara MedTech Inc. Healthcare Nov 12 Sep '26 $28.0M +7.7% −$1.0M n/m −$0.16 n/m 2.6% −8.7 pp $301M
ALTAltimmune, Inc. Healthcare Nov 12 Sep '26 $0.0M n/m −$32.0M n/m −$0.15 n/m — — $298M
KYTXKyverna Therapeutics, Inc. Healthcare Nov 12 Sep '26 $0.0M n/m −$42.0M n/m −$0.68 n/m — — $297M
EVMNEvommune, Inc. Healthcare Nov 12 Sep '26 $0.0M −100.0% −$31.0M n/m −$0.85 n/m — — $290M
FULCFulcrum Therapeutics, Inc. Healthcare Nov 12 Sep '26 $0.0M n/m −$11.0M n/m −$0.14 n/m — — $286M
NPCENeuropace, Inc. Healthcare Nov 12 Sep '26 $23.0M −14.8% −$3.0M n/m −$0.10 n/m -9.0% +0.5 pp $283M
EIKNEikon Therapeutics, Inc. Healthcare Nov 12 Sep '26 $0.0M n/m −$86.0M n/m −$1.59 n/m — — $279M
SCTXScribe Therapeutics Inc. Healthcare Nov 12 Sep '26 $2.0M — −$10.0M — −$0.52 — -663.9% — $255M
IPSCCentury Therapeutics, Inc. Healthcare Nov 12 Sep '26 $0.0M n/m −$23.0M n/m −$0.11 n/m — — $249M
RCKTRocket Pharmaceuticals, Inc. Healthcare Nov 12 Sep '26 $0.0M n/m −$49.0M n/m −$0.43 n/m — — $236M
LCTXLineage Cell Therapeutics, Inc. Healthcare Nov 12 Sep '26 $1.0M n/m $4.0M n/m −$0.03 n/m -510.0% — $206M
ETRAElectra Therapeutics Inc. Healthcare Nov 12 Sep '26 $0.0M — −$24.0M — −$0.38 — — — $177M
MDWDMediWound Ltd. Healthcare Nov 12 Sep '26 $4.0M −20.0% −$6.0M n/m −$0.46 n/m -239.3% −119.1 pp $177M
  • Report dates come from the earnings calendar (dates loaded Oct 4 to Dec 9); figures come from the quarterly statements stored for each company. Click a ticker for its full statements.
  • YoY compares the reported quarter with the same quarter a year earlier. n/m (not meaningful) means the year-earlier figure was zero or negative, so a percentage change would not describe it. Margin change is in percentage points.
  • pending: the company has reported, but that quarter is not in our statements yet. Revenue marked † is the announced figure from the earnings calendar; the other columns fill in once the statements update.

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.